Vietnam stock market starts June with modest gain
HANOI: Vietnam's stock market started June on a positive note, with a modest gain on Monday, primarily driven by small and mid-cap stocks.
The VN-Index recovered the 1,335-point mark despite early pressure from large-cap declines, while liquidity eased slightly and foreign investors continued to sell, albeit at a reduced pace.
Early on, the market experienced downward pressure from a number of large-cap stocks, briefly pulling the VN-Index below 1,325 points.
However, continued cash inflows into small and mid-cap shares helped the rebound to end higher.
By the close of trading, the VN-Index rose 3.7 points, or 0.28%, to 1,336.3 points on the Ho Chi Minh Stock Exchange.
Market breadth leaned towards the gainers, with 201 stocks advancing and 125 declining. Liquidity fell by 6.7% from the previous session to 0.8 trillion dong.
The VN30-Index, which tracks the 30 largest listed companies by market capitalisation, edged down 0.64 points, or 0.04%, to 1,423.04. Within the basket, 16 stocks gained, 13 declined and one remained unchanged.
Leading the market's upward momentum was Vietnam Rubber Group – Joint Stock Co, which climbed 2.09% and contributed over 0.6 points to the VN-Index.
It was followed by gains in two banking stocks: Techcombank, up 1.31%, and Sacombank, which rose 2.7%.
On the other hand, several major stocks posted losses and that weighed on the index.
The Vingroup cluster led the decliners, collectively dragging the VN-Index down by nearly five points, with VIC being the most notable, slipping 0.41%.
Analysts from Viet Dragon Securities said: 'The market continued to face resistance at the 1,345-point level and retreated.
'Liquidity declined slightly compared to the previous session, suggesting reduced profit-taking activity and easing selling pressure, particularly as foreign outflows moderated. — Viet Nam News/ANN
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malaysian Reserve
2 days ago
- Malaysian Reserve
Halozyme Therapeutics Added to Russell 1000® Index
SAN DIEGO, June 30, 2025 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) (Halozyme) today announced that it has been added to the U.S. large-cap Russell 1000® Index, effective after market close on June 27th, as part of the 2025 FTSE Russell indexes annual reconstitution. The Russell 1000® Index includes approximately 1,000 of the largest U.S. securities based on market capitalization and is widely used by investors as a benchmark for the performance of large-cap stocks. 'Joining the Russell 1000 Index is an important milestone that reflects our leadership in rapid large-volume subcutaneous drug delivery and our track record of durable top-and-bottom line growth,' said Dr. Helen Torley, President and CEO of Halozyme. 'The inclusion will help to expand our visibility among the investment community as we continue to execute our strategy and deliver sustainable growth and profitability well into the future.' The Russell 1000® is managed by FTSE Russell, a global leader in index and analytics. Membership in the Russell 1000® Index, which remains in place for one year, is based on membership in the broad-market Russell 3000® Index. About Halozyme Halozyme is a biopharmaceutical company advancing disruptive solutions to improve patient experiences and outcomes for emerging and established therapies. As the innovators of ENHANZE® drug delivery technology with the proprietary enzyme rHuPH20, Halozyme's commercially-validated solution is used to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid subcutaneous delivery and reduced treatment burden. Having touched one million patient lives in post-marketing use in ten commercialized products in at least one major region and across more than 100 global markets, Halozyme has licensed its ENHANZE® technology to leading pharmaceutical and biotechnology companies including Roche, Takeda, Pfizer, Janssen, AbbVie, Eli Lilly, Bristol-Myers Squibb, argenx, ViiV Healthcare, Chugai Pharmaceutical and Acumen Pharmaceuticals. Halozyme also develops, manufactures and commercializes, for itself or with partners, drug-device combination products using its advanced auto-injector technologies that are designed to provide commercial or functional advantages such as improved convenience, reliability and tolerability, and enhanced patient comfort and adherence. The Company has two commercial proprietary products, Hylenex® and XYOSTED®, partnered commercial products and ongoing product development programs with Teva Pharmaceuticals and McDermott Laboratories Limited, an affiliate of Viatris Inc. Halozyme is headquartered in San Diego, CA and has offices in Ewing, NJ and Minnetonka, MN. Minnetonka is also the site of its operations facility. For more information visit and connect with us on LinkedIn and Twitter. Safe Harbor Statement In addition to historical information, the statements set forth above include forward-looking statements including, without limitation, statements concerning the future execution of Halozyme's strategy and delivery of future sustainable growth and profitability, the durability of Halozyme's top and bottom line growth, the possible activity, benefits and attributes of ENHANZE®, the possible method of action of ENHANZE®, its potential application to aid in the dispersion and absorption of other injected therapeutic drugs, and statements concerning certain other potential benefits of ENHANZE® including facilitating more rapid delivery of injectable medications through subcutaneous delivery and potentially lowering the treatment burden for patients. These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. The forward-looking statements are typically, but not always, identified through use of the words 'expect,' 'believe,' 'enable,' 'may,' 'will,' 'could,' 'intends,' 'estimate,' 'anticipate,' 'plan,' 'predict,' 'probable,' 'potential,' 'possible,' 'should,' 'continue,' and other words of similar meaning. Actual results could differ materially from the expectations contained in forward-looking statements as a result of several factors, including unexpected results in the execution of Halozyme's strategy and unexpected future financial results and top and bottom line growth,. These and other factors that may result in differences are discussed in greater detail in Halozyme's most recent Annual and Quarterly Reports filed with the Securities and Exchange Commission. Except as required by law, Halozyme undertakes no duty to update forward-looking statements to reflect events after the date of this release. Contacts: Tram BuiVP, Investor Relations and Corporate Communications609-333-7668tbui@ Sydney
Malay Mail
2 days ago
- Malay Mail
Vietnam launches sweeping anti-corruption push, tightens grip on public funds
HANOI, July 1 — The Vietnamese government has unveiled an action plan to overhaul oversight of public finances and assets, endorsing a Politburo's regulation to curb corruption and bolster accountability, Vietnam News Agency (VNA) reported a resolution issued this week. The plan, designed to align with the party's directives, aims to embed rigorous controls over power and prevent abuse in managing state resources. A core goal is to ensure that leaders, including heads of agencies and decision-making officials, are held to higher standards of accountability. The plan highlights transparent leadership and robust management to protect the integrity of public financial systems. The resolution mandates intensified scrutiny of ministries, agencies, and local authorities, with a focus on how they wield authority over public funds and property. Senior leaders are expected to lead by example, embracing transparency, public accountability, and a culture of self-criticism in their organisations. To enforce compliance, the government will ramp up inspections, audits, and sector-specific reviews to detect and deter misconduct while ensuring adherence to party guidelines and state laws. According to VNA, the plan also calls for a restructuring of the public workforce, prioritising the recruitment and training of officials who demonstrate not only professional competence but also integrity and dedication to public service. To mitigate corruption risks, regular job rotations and position changes are mandated for officials involved in advising, allocating and managing public finances, aiming to prevent entrenched power and foster professional growth. Moreover, the plan advocates for protecting whistleblowers while cracking down on malicious or defamatory complaints, ensuring that anti-corruption efforts remain fair and effective. — Bernama-VNA
The Star
6 days ago
- The Star
Global uncertainty weighs on Vietnam's economic outlook
Dragon fruit prepared for export in Bình Thuan Province. Vietnam's economic outlook is heavily dependent on the outcome of trade negotiations. — VNA/VNS HANOI: Vietnam's economic outlook is heavily dependent on the outcome of trade negotiations and is constrained by elevated global uncertainty on trade policies and economic growth, according to an International Monetary Fund (IMF) team led by Paulo Medas. The team has concluded discussions for the 2025 Article IV consultation with Vietnamese authorities from June 11 to 24. According to the IMF team, high tariffs will likely take effect in the third quarter. In such a scenario, economic growth is projected to slow to 5.4 per cent in 2025 and decelerate further in 2026. However, if global trade tensions subside, the economic outlook would improve significantly. 'Downside risks are high. A further escalation in global trade tensions or a tightening of global financial conditions could weaken further exports and investment,' Paulo said. Domestically, financial stress could re-emerge from tighter financial conditions and high corporate indebtedness, he added. On the upside, achieving non-discriminatory trade agreements and successfully implementing planned infrastructure and structural reforms could significantly boost medium-term growth. 'Given the uncertain outlook, policy priorities should focus on preserving macro-financial stability while navigating economic adjustments. Fiscal policy, supported by a low level of public debt, should take the lead in cushioning the near-term impact, especially under downside scenarios. Accelerated implementation of public investment and strengthening social safety nets would be important,' he stressed. He pointed out that monetary policy has much more limited room and should be decisively focused on anchoring inflation expectations. Allowing the exchange rate flexibility will be critical as the economy adjusts to the external shock. Some monetary easing could be considered if global interest rates decline as expected and inflation falls. Vigilance is needed to monitor and act against inflation pressures that may arise, including due to external shocks. These challenges underscore the importance of modernising the monetary policy framework to enhance its effectiveness and anchor stability, including by replacing credit growth limits with an improved prudential framework. 'Further efforts are needed to strengthen financial sector soundness. To bolster banking system resilience, priorities include strengthening bank supervision, build liquidity and capital buffers, and further improving the bank resolution framework,' he said. 'The Government's plans for an ambitious reform agenda are very welcome and could boost medium-term growth, but implementation will be key.' — Vietnam News/ANN
